Orchard picks PharmaCell to make its autologous cell therapies
Orchard Therapeutics has selected Dutch CMO PharmaCell to manufacture products from its gene therapy pipeline.
Archives for January 9, 2017
Drug discovery collaboration could lead to a long-term clinical development effort
Sharp Edge Labs will use its propriety biosensor platform to identify lead compounds for Sumitomo Dainippon Pharma – technology that the company says will help focus discussions on outcomes rather than cost.
US DEA finalises controlled substance and equipment revisions
Drugmakers must include a transaction identification number when buying or selling machinery for tabletting or encapsulating controlled substances, according to a final ruling from the US DEA.
Almac Group introduces Almac Clinical University
The Almac Group has launched a web-based training and education platform to house clinical trial guidance and advice.
Danish regulators ban Europharma DK ApS and suggest firm needs new CEO
Danish regulators have banned Europharma DK ApS from making or importing medicines and drug intermediates after identifying serious breaches of GMP at its plant in Esbjerg.
Aurobindo to add Portuguese capsule and tablet capacity through Generis Farmaceutica buy
Aurobindo Pharma Limited has agreed to buy Portugal-based Generis Farmaceutica SA for €135m in a deal that includes a tablet and capsule plant in Amadora.
Worldwide Clinical Trials to support Ph III trial for Renova Therapeutics
Worldwide Clinical Trials will support the full scope of Renova Therapeutics Phase III trial for its lead gene therapy product candidate, says the CRO.
Risk in global logistics: the top overlooked factors
Paid for and content provided by World Courier
World Courier shares an overview of the current risks inherent to the pharmaceutical supply chain in 2017.